IP Verse

Method For Suppressing Bitterness Of Quinoline Derivative - EP3263106

The patent EP3263106 was granted to Eisai R&D Management on Oct 25, 2023. The application was originally filed on Feb 23, 2016 under application number EP16755489A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3263106

EISAI R&D MANAGEMENT
Application Number
EP16755489A
Filing Date
Feb 23, 2016
Status
Granted And Under Opposition
Sep 22, 2023
Grant Date
Oct 25, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (8)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCAREJul 25, 2024UEXKULL & STOLBERGADMISSIBLE
GENERICS UKJul 25, 2024ELKINGTON AND FIFEADMISSIBLE
STADA ARZNEIMITTELJul 25, 2024HAMM & WITTKOPPADMISSIBLE
SYNTHONJul 25, 2024HAMM & WITTKOPPADMISSIBLE
WELDINGJul 25, 2024HAMM & WITTKOPPADMISSIBLE
MAIWALDJul 23, 2024MAIWALDADMISSIBLE
TEVA PHARMACEUTICALSJul 12, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE
SANDOZJun 20, 2024ELKINGTON AND FIFEADMISSIBLE

Patent Citations (33) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONEP1894918
EXAMINATIONIN2371CHENP201
EXAMINATIONUS2007078159
EXAMINATIONUS2008214604
INTERNATIONAL-SEARCH-REPORTJPH05194259
INTERNATIONAL-SEARCH-REPORTWO2006030826
INTERNATIONAL-SEARCH-REPORTWO2008053602
INTERNATIONAL-SEARCH-REPORTWO2011021597
OPPOSITIONEP0582396
OPPOSITIONEP1894918
OPPOSITIONEP2821066
OPPOSITIONIN2371CHENP2012
OPPOSITIONJP2009263298
OPPOSITIONJPH05194259
OPPOSITIONUS2006198885
OPPOSITIONUS2007078159
OPPOSITIONUS2007292515
OPPOSITIONUS2008214604
OPPOSITIONUS2012077842
OPPOSITIONUS2012077852
OPPOSITIONUS2013237565
OPPOSITIONUS4656027
OPPOSITIONUS5633006
OPPOSITIONWO03077842
OPPOSITIONWO2004096214
OPPOSITIONWO2006030826
OPPOSITIONWO2008053602
OPPOSITIONWO2011021597
OPPOSITIONWO2012029913
OTHERUS2008214604
OTHERUS2012077842
SEARCHUS2012077842
SEARCHUS2013237565

Non-Patent Literature (NPL) Citations (38) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Alderborn Goran, "Tablets and compaction", Pharmaceutics: The Science of Dosage Form Design, Churchill Livingstone, (20020101), pages 397 - 440, XP093109030-
OPPOSITION- A.M. Campeta, "Magnesium Oxide", A.M. Campeta, Raymond C Rowe; Paul J Sheskey; Marian E Quinn (eds.), Handbook of Pharmaceutical Excipients, UK , Pharmaceutical Press , (20090101), pages 400 - 402, ISBN 978-0-85369-792-3, XP009556859-
OPPOSITION- Anonymous, "Alkaloid ", Wikipedia, (20150216), pages 1 - 21, Wikipedia , URL: https://en.wikipedia.org/w/index.php?title=Alkaloid&oldid=647404017, (20240816), XP093195750-
OPPOSITION- Anonymous, "Guideline on pharmaceutical development of medicines for paediatric use", EUROPEAN MEDICINES AGENCY; EMA/CHMP/QWP/805880/2012 Rev. 2 Committee for Medicinal Products for Human Use (CHMP) Paediatric Committee (PDCO), (20130801), XP093197800-
OPPOSITION- Anonymous, "How to give medicines: tablets (Version 1)", Medicines for Children, (20111201), Medicines for Children, URL: https://www.medicinesforchildren.org.uk/wp-content/uploads/sites/8/2021/10/How-to-give-tablets.pdf, XP093194639-
OPPOSITION- Anonymous, "Lenvima - Highlights of Prescribing Information", FDA, (20150201), XP093198831-
OPPOSITION- Anonymous, "LENVIMA (lenvatinib) capsules 4 and 10 mg", CENTER FOR DRUG EVALUATION AND RESEARCH (FDA), (20150205), XP093198823-
OPPOSITION- Anonymous, "Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma; NCT02432274", ClinicalTrials.gov; NCT02432274, (20160126), ClinicalTrials.gov; NCT02432274, URL: https://clinicaltrials.gov/study/NCT02432274?tab=history&a=6#version-content-panel, XP093198818-
OPPOSITION- Artur Burger, Helmut Wachter, "Passage; Hunnius Pharmazeutisches Wörterbuch", Artur Burger, Helmut Wachter, Artur Burger, Helmut Wachter, Hunnius Pharmazeutisches Wörterbuch, 7. Auflage, Berlin, New York, Walter de Gruyter, (19930101), page 221, ISBN 3-11-013868-9, XP009556953-
OPPOSITION- BRIAN JONES, "29 Hard gelatin capsules", BRIAN JONES, M.E. AULTON, Pharmaceutics: The Science of Dosage Form Design, 2nd Edition, CHURCHILL LIVINGSTONE, (20020101), pages 449 - 460, ISBN 0-443-10107-8, XP009559174-
OPPOSITION- European Medicines Agency Ema, "Assessment report Lenvima. International non-proprietary name: lenvatinib", EMA Procedure No. EMEA/H/C/003727/0000, (20150326), pages 1 - 170, XP055910213-
OPPOSITION- Felton Linda, "Chapter 20: Colloidal Dispersions", Remington, Essentials of Pharmaceutics, GB, Pharmaceutical Press , (20120101), pages 343 - 370, ISBN 978-0-85711-105-0, XP055920161-
OPPOSITION- Harmik Sohi, Yasmin Sultana and Roop K. Khar, "Taste Masking Technologies in Oral Pharmaceuticals: Recent Developments and Approaches", Journal Drug Development and Industrial Pharmacy, NEW YORK, NY, US, US , (20040101), vol. 30, no. 5, ISSN 0363-9045, pages 429 - 448, XP009139647-
OPPOSITION- Kharb Vandana , Vikas Anand Saharan, Anupama Singh, Hemant Jadhav , Suresh Purohit, "Bitterness Suppression of Oral Pharmaceuticals", Kharb Vandana , Vikas Anand Saharan, Anupama Singh, Hemant Jadhav , Suresh Purohit, Elizabeth J Lynch , Alexander P Petrov, Otolaryngology Research Advances The sense of taste , New York, Nova Science Publishers, Inc, (20120101), pages 237 - 267, ISBN 978-1-61209-748-0, XP093195740-
OPPOSITION- Kharb Vandana , Vikas Anand Saharan, Anupama Singh, Hemant Jadhav , Suresh Purohit, "Bitterness Suppression of Oral Pharmaceuticals", Otolaryngology Research Advances The sense of taste , New York, Nova Science Publishers, Inc, (20120101), pages 237 - 267, ISBN 978-1-61209-748-0, XP093195740-
OPPOSITION- "Körperoberfläche", Helmut Hildebrandt, Pschyrembel Klinisches Wörterbuch (257. Auflage), Berlin, Walter de Gruyter, (19940101), pages 796 - 798, ISBN 3-11-012692-3, XP009556749-
OPPOSITION- "Körperoberfläche", Wörterbuch-Redaktion des Verlages unter Leitung von Helmut Hildebrandt, Pschyrembel Klinisches Wörterbuch (257. Auflage), Berlin, Walter de Gruyter, (19940101), pages 796 - 798, ISBN 3-11-012692-3, XP009556749-
OPPOSITION- Masha S H Lam, "Extemporaneous Compounding of Oral Liquid Dosage Formulations and Alternative Drug Delivery Methods for Anticancer Drugs", Pharmacotherapy, (20110201), vol. 31, no. 2, pages 164 - 192, XP055863221-
OPPOSITION- Michael Billany, "Chapter 23: Suspensions and emulsions", Michael Billany, M.E. Aulton, Pharmaceutics: The Science of Dosage Form Design, 2nd Edition, Churchill Livingstone, (20020101), pages 334 - 359, ISBN 0443055173, XP009559173-
OPPOSITION- Peter York, "Chapter 1: The design of dosage forms", PHARMACEUTICS: THE SCIENCE OF DOSAGE FORM DESIGN, Second Edition, Elsevier , (20020101), pages 1 - 12, ISBN 0-443-05517-3, XP009555448-
OPPOSITION- Premavalli K S, Y. S. Satyanarayana Swamy, "Taste of Foods", Premavalli K S, Y. S. Satyanarayana Swamy, Elizabeth J Lynch , Alexander P Petrov, Otolaryngology Research Advances The sense of taste , New York, Nova Science Publishers, Inc, (20120101), pages 1 - 20, ISBN 978-1-61209-748-0, XP093195735-
OPPOSITION- R.C. Rowe, "Calcium Carbonate", R.C. Rowe, R.C. Rowe, Handbook of Pharmaceutical Excipients, 6th Edition, London, Chicago, Pharmaceutical Press, American Pharmacists Association, (20090205), pages 86 - 89, ISBN 9780853697923, XP009556954-
OPPOSITION- Rebecca White, "Chapter 2: Types of enteral feeding tubes", Rebecca White, Rebecca White and Vicky Bradnam, Handbook of Drug Administration via Enteral Feeding Tubes, PHARMACEUTICAL PRESS, (20070101), pages 4 - 8, ISBN 978-0-85369-648-3, XP009559176-
OPPOSITION- REBECCA WHITE, "Chapter 6: Choice of medication formulation", REBECCA WHITE, REBECCA WHITE AND VICKY BRADNAM, Handbook of Drug Administration via Enteral Feeding Tubes, PHARMACEUTICAL PRESS, (20070101), pages 23 - 34, ISBN 978-0-85369-648-3, XP009559175-
OPPOSITION- Reiland T.L. Et Al., "Flavors and flavor modifiers", Encyclopedia of Pharmaceutical Technology, third edition, Informa Healthcare USA, Inc., (20070101), pages 2pp,1763 - 1772, XP055275318-
OPPOSITION- Rodney J. Wigent, "Chapter 17 Chemical Kinetics", Rodney J. Wigent, Linda Felton, Remington, Essentials of Pharmaceutics, GB, Pharmaceutical Press , (20130101), pages 301 - 315, ISBN 978-0-85711-105-0, XP009559148-
OPPOSITION- Swarbrick James, Joseph T. Rubino,Orapin P. Rubino, "Chapter 21: Coarse Dispersions", Remington, Essentials of Pharmaceutics, GB, Pharmaceutical Press , (20120101), pages 371 - 391, ISBN 978-0-85711-105-0, XP093226355-
OPPOSITION- Tanaka T., Et Al., "Bioequivalence Test for Tandospirone citrate tablet 10 mg "AMEL"", Journal of New Remedies & Clinics, (20080101), vol. 57, no. 6, XP093194637-
OPPOSITION- Vandana Kharb, Vikas Anand Saharan, Anupama Singh, Hemant Jadhav, Suresh Purohit, "Chapter 16 Bitterness Suppression of Oral Pharmaceuticals", Vandana Kharb, Vikas Anand Saharan, Anupama Singh, Hemant Jadhav, Suresh Purohit, Elizabeth J. Lynch, Alexander P. Petrov, The Sense of Taste, New York, Nova Science Publishers, Inc., (2012), page 237-276, ISBN 978-1-61209-748-0, XP093195740-
OPPOSITION- Jennifer Walsh et al., "Playing hide and seek with poorly tasting paediatric medicines: Do not forget the excipients", Advanced Drug Delivery Reviews, (20140312), vol. 73, doi:10.1016/j.addr.2014.02.012, XP028855087
OPPOSITION- J. Walsh et al., "Playing hide and seek with poorly tasting paediatric medicines: Do not forget the excipients", Advanced Drug Delivery Reviews, (2014), vol. 73, doi:10.1016/j.addr.2014.02.012, XP028855087
OPPOSITION- Walsh Jennifer; Cram Anne; Woertz Katharina; Breitkreutz Joerg; Winzenburg Gesine; Turner Roy; Tuleu Catherine, "Playing hide and seek with poorly tasting paediatric medicines: Do not forget the excipients", Advanced Drug Delivery Reviews, Amsterdam , NL , (20140312), vol. 73, doi:10.1016/j.addr.2014.02.012, ISSN 0169-409X, pages 14 - 33, XP028855087
OPPOSITION- Fleuren Emmy D.G., Versleijen-Jonkers Yvonne M.H., Boerman Otto C., Van Der Graaf Winette T.A., "Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: Current hurdles and future perspectives", Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, ELSEVIER SCIENCE BV, AMSTERDAM., NL, NL , (20140401), vol. 1845, no. 2, doi:10.1016/j.bbcan.2014.02.005, ISSN 0304-419X, pages 266 - 276, XP093119212
OPPOSITION- Pydi Sai P., Sobotkiewicz Tyler, Billakanti Rohini, Bhullar Rajinder P., Loewen Michele C., Chelikani Prashen, "Amino Acid Derivatives as Bitter Taste Receptor (T2R) Blockers", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (20140901), vol. 289, no. 36, doi:10.1074/jbc.M114.576975, ISSN 0021-9258, pages 25054 - 25066, XP093198154
OPPOSITION- Gelnn M. Roy, "The applications and future implications of bitterness reduction and inhibition in food products", Critical reviews in food science and nutrition, Taylor & Francis, USA, USA , (19900101), vol. 29, no. 2, doi:10.1080/10408399009527516, ISSN 1040-8398, pages 59 - 71, XP009134690
OPPOSITION- K. Yamada, N. Yamamoto, Y. Yamada, H. Nokihara, Y. Fujiwara, T. Hirata, F. Koizumi, K. Nishio, N. Koyama, T. Tamura, "Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors", Clinical Cancer Research, Association for Cancer Research, (20110415), vol. 17, no. 8, doi:10.1158/1078-0432.CCR-10-2638, ISSN 10780432, pages 2528 - 2537, XP055189216
OPPOSITION- Lam Masha S., "Extemporaneous Compounding of Oral Liquid Dosage Formulations and Alternative Drug Delivery Methods for Anticancer Drugs", Pharmacotherapy, US , (20110201), vol. 31, no. 2, doi:10.1592/phco.31.2.164, ISSN 0277-0008, pages 164 - 192, XP093194630
OPPOSITION- Lam Masha S., "Extemporaneous Compounding of Oral Liquid Dosage Formulations and Alternative Drug Delivery Methods for Anticancer Drugs", Pharmacotherapy, Wiley-Blackwell, US, US , (20110201), vol. 31, no. 2, doi:10.1592/phco.31.2.164, ISSN 0277-0008, pages 164 - 192, XP093194630

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents